|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
ELV035826266 |
003 |
DE-627 |
005 |
20230624024103.0 |
007 |
cr uuu---uuuuu |
008 |
180603s2017 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.pcd.2017.02.004
|2 doi
|
028 |
5 |
2 |
|a GBV00000000000085A.pica
|
035 |
|
|
|a (DE-627)ELV035826266
|
035 |
|
|
|a (ELSEVIER)S1751-9918(17)30027-X
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
082 |
0 |
|
|a 610
|
082 |
0 |
4 |
|a 610
|q DE-600
|
082 |
0 |
4 |
|a 630
|q VZ
|
082 |
0 |
4 |
|a 640
|q VZ
|
082 |
0 |
4 |
|a 590
|q VZ
|
082 |
0 |
4 |
|a 610
|q VZ
|
082 |
0 |
4 |
|a 600
|q VZ
|
084 |
|
|
|a 50.70
|2 bkl
|
100 |
1 |
|
|a Cigrovski Berković, Maja
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Impact of health policy and practice on finding the best fit for patients with type 2 diabetes after metformin failure: Croatian pilot study
|
264 |
|
1 |
|c 2017
|
300 |
|
|
|a 8
|
336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
520 |
|
|
|a • Resolve a problem of unmet needs for glycemic improvement in primary care setting. • Define the most acceptable second line agent for treatment of T2DM. • Addition of DPP-4 and SU resulted in successful glucose control with no side effects. • More aggressive approach needed by primary care physicians with early intensification of therapy using available agents.
|
650 |
|
7 |
|a Oral hypoglycemic agents
|2 Elsevier
|
650 |
|
7 |
|a Metformin failure
|2 Elsevier
|
650 |
|
7 |
|a HbA1c
|2 Elsevier
|
650 |
|
7 |
|a Croatian setting
|2 Elsevier
|
650 |
|
7 |
|a Diabetes mellitus type 2
|2 Elsevier
|
700 |
1 |
|
|a Herman Mahečić, Davorka
|4 oth
|
700 |
1 |
|
|a Gradišer, Marina
|4 oth
|
700 |
1 |
|
|a Bilić-Ćurčić, Ines
|4 oth
|
773 |
0 |
8 |
|i Enthalten in
|n Elsevier
|a David, Lauren A. ELSEVIER
|t A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients
|d 2016
|g Amsterdam [u.a.]
|w (DE-627)ELV024210129
|
773 |
1 |
8 |
|g volume:11
|g year:2017
|g number:3
|g pages:265-272
|g extent:8
|
856 |
4 |
0 |
|u https://doi.org/10.1016/j.pcd.2017.02.004
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_U
|
912 |
|
|
|a GBV_ELV
|
912 |
|
|
|a SYSFLAG_U
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_60
|
912 |
|
|
|a GBV_ILN_72
|
912 |
|
|
|a GBV_ILN_227
|
912 |
|
|
|a GBV_ILN_350
|
936 |
b |
k |
|a 50.70
|j Energie: Allgemeines
|q VZ
|
951 |
|
|
|a AR
|
952 |
|
|
|d 11
|j 2017
|e 3
|h 265-272
|g 8
|
953 |
|
|
|2 045F
|a 610
|